| Cell line name |
NOM1 |
|---|
| Synonyms |
Nagoya Ovarian Mucinous 1 |
|---|
| Accession |
CVCL_RN35 |
|---|
| Resource Identification Initiative |
To cite this cell line use: NOM1 (RRID:CVCL_RN35) |
|---|
| Comments |
Population: Japanese. |
|---|
| Disease |
Ovarian mucinous adenocarcinoma (NCIt: C5243)
Mucinous adenocarcinoma of ovary (ORDO: Orphanet_398961) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Female |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=8978593; DOI=10.1159/000227661
Yasunori Wakahara, Akihiro Nawa, Tomomitsu Okamoto, Akemi Hayakawa, Fumitaka Kikkawa, Nobuhiko Suganama, Fumiyo Wakahara, Yutaka Tomoda;
Combination effect of anti-Fas antibody and chemotherapeutic drugs in ovarian cancer cells in vitro.
Oncology 54:48-54(1997) PubMed=9344045; DOI=10.1023/A:1018495414975
Kiyosumi Shibata, Fumitaka Kikkawa, Akihiro Nawa, Koji Tamakoshi, Nobuhiko Suganuma, Yutaka Tomoda;
Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.
Clin. Exp. Metastasis 15:612-619(1997) PubMed=9891486
Fumitaka Kikkawa, Akihiro Nawa, Kiyosumi Shibata, Naoko H. Obata, Koji Tamakoshi, Shoji Suzuki, Shigehiko Mizutani;
The different stimulatory effect of normal tissues on the secretion of matrix metalloproteinases and their inhibitors by human ovarian cancer cells.
Anticancer Res. 18:4323-4328(1998) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54930894
|
|---|
| Entry history |
|---|
| Entry creation | 05-Mar-2018 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 5 |
|---|
